Imunon, Inc. (IMNN)
3.51
+0.27
(+8.33%)
USD |
NASDAQ |
Feb 10, 09:49
Imunon Market Cap : 7.448M for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cellectar Biosciences, Inc. | 5.816M |
| PDS Biotechnology Corp. | 38.30M |
| PAVmed, Inc. | 10.13M |
| ACADIA Pharmaceuticals, Inc. | 3.903B |
| Alnylam Pharmaceuticals, Inc. | 42.68B |
Market Cap Related Metrics
| PEG Ratio | -0.0018 |
| Price to Book Value | 1.825 |
| Price | 3.51 |
| Earnings Yield | -198.4% |
| PEGY Ratio | -0.0018 |